EWM
ACER

Edge Wealth Management’s Acer Therapeutics Inc ACER Stock Holding History

Edge Wealth Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50
Closed -$1K – 484
2021
Q4 		$1K Buy
+50
New +$116 ﹤0.01% 505

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return

Edge Wealth Management's ACER Position: Q1 2022 in Review

Edge Wealth Management sold out of Acer Therapeutics Inc (ACER) in Q1 2022, closing a stake of 50 shares — an estimated $1K sold.

Edge Wealth Management first reported a position in ACER in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 21 funds tracked by Wall St. Rank hold ACER as of Q1 2022.

  • Edge Wealth Management reported no remaining Acer Therapeutics Inc position as of Q1 2022 after selling out during the quarter.
  • Edge Wealth Management sold 50 Acer Therapeutics Inc shares in Q1 2022, an estimated $1K.
  • Edge Wealth Management first reported a position in Acer Therapeutics Inc in Q4 2021 and held it in 1 quarter.
  • Edge Wealth Management's Acer Therapeutics Inc position peaked at $1K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2022.

Based on Edge Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.